Greetings and welcome to PDS Biotechnology Second Quarter 2021 Financial Results. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over ...

9 partial responses (3 cervical cancer, 2 vulvar/vaginal cancer, 2 anal cancer, 2 oropharyngeal cancer) 90% of these of these responses are ongoing after a median 5 months of follow up (9/10) The NCI ...

London, UK - 10 November 2021- NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company ...

A live webcast of the conference call will also be available on the investor relations page of the Company's website at www.pdsbiotech.com. After the live webcast, the event will be archived on PDS ...

FLORHAM PARK, N.J., April 29, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease ...

FLORHAM PARK, N.J., Feb. 22, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease ...

Ladies and gentlemen, thank you for standing by, and welcome to the Precision Drilling Corporation 2021 First Quarter Results Conference Call and Webcast. At this time, all participants' lines are in ...

Roche RHHBY announced that the FDA has accepted its Biologics License Application (BLA) for Port Delivery System with ranibizumab (PDS) for the treatment of neovascular or “wet” age-related macular ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention that ...